Td Asset Management Inc Gilead Sciences, Inc. Transaction History

Td Asset Management Inc

$106 Billion
Q4 2024

A detailed history of Td Asset Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 1,092,705 shares of GILD stock, worth $116 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,092,705

Previous 779,446 40.19%

Holding current value

$116 Million

Previous $65.3 Million 54.49%

% of portfolio

0.1%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$83.95 - $97.9 $26.3 Million - $30.7 Million	313,259 Added 40.19%	1,092,705 $101 Million
Q3 2024 Nov 01, 2024	BUY	$66.59 - $83.99 $3.48 Million - $4.39 Million	52,289 Added 7.19%	779,446 $65.3 Million
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $20.7 Million - $23.9 Million	-328,023 Reduced 31.09%	727,157 $49.9 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $1.83 Million - $2.23 Million	25,523 Added 2.48%	1,055,180 $77.3 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $18.8 Million - $21.3 Million	256,039 Added 33.1%	1,029,657 $83.4 Million
Q3 2023 Oct 27, 2023	SELL	$73.94 - $80.67 $8.72 Million - $9.52 Million	-118,000 Reduced 13.23%	773,618 $58 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $7.73 Million - $8.81 Million	-101,640 Reduced 10.23%	891,618 $68.7 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $660,536 - $752,555	-8,544 Reduced 0.85%	993,258 $82.4 Million
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $1.83 Million - $2.62 Million	-29,329 Reduced 2.84%	1,001,802 $86 Million
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $607,784 - $694,246	10,208 Added 1.0%	1,031,131 $65 Million
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $5.01 Million - $5.64 Million	86,772 Added 9.29%	1,020,923 $63.1 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $3.44 Million - $4.31 Million	59,414 Added 6.79%	934,151 $55.5 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $209,043 - $237,268	3,222 Added 0.37%	874,737 $63.5 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $359,704 - $388,081	5,314 Added 0.61%	871,515 $60.9 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $7.3 Million - $7.98 Million	115,024 Added 15.31%	866,201 $59.2 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $12.8 Million - $14.6 Million	213,988 Added 39.83%	751,177 $48.5 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.89 Million - $2.16 Million	33,449 Added 6.64%	537,189 $31.3 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $7.92 Million - $9.96 Million	127,610 Added 33.93%	503,740 $31.8 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $535,460 - $621,768	-7,402 Reduced 1.93%	376,130 $28.9 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.02 Million - $1.31 Million	-16,283 Reduced 4.07%	383,532 $28.7 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $2.27 Million - $2.5 Million	-36,836 Reduced 8.44%	399,815 $26 Million
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $1.58 Million - $1.75 Million	-25,349 Reduced 5.49%	436,651 $27.7 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $768,920 - $862,254	-12,428 Reduced 2.62%	462,000 $31.2 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $4.17 Million - $4.67 Million	-66,702 Reduced 12.33%	474,428 $30.8 Million
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $82,576 - $107,756	-1,364 Reduced 0.25%	541,130 $33.8 Million
Q3 2018 Nov 01, 2018	SELL	$71.28 - $78.92 $1.29 Million - $1.43 Million	-18,122 Reduced 3.23%	542,494 $41.9 Million
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $28.4 Million - $33.1 Million	-436,963 Reduced 43.8%	560,616 $39.7 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $3.16 Million - $3.85 Million	-43,349 Reduced 4.16%	997,579 $75.2 Million
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $524,873 - $616,127	-7,377 Reduced 0.7%	1,040,928 $74.6 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $75.6 Million - $89.6 Million	1,048,305	1,048,305 $84.9 Million

Others Institutions Holding GILD

# of Institutions

2,045

Shares Held

Call Options Held

10M

Put Options Held

9.05M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $133B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Gilead Sciences, Inc. Transaction History